IDEAYA Biosciences (IDYA) Interest & Investment Income (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Interest & Investment Income of -$2.8 million for Q1 2026, down 1384.19% sequentially from $215000.0 in Q4 2025, and down 457.18% YoY from $773000.0 in Q1 2025.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Interest & Investment Income (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Interest & Investment Income for 8 years, with the latest figure at -$2.8 million in Q1 2026.
- Quarterly Interest & Investment Income fell 457.18% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 182.89% YoY) and the FY2025 annual result came in at $1.5 million, up 482.0% from the prior year.
- Interest & Investment Income declined to -$2.8 million in Q1 2026 per IDYA's latest filing, from $215000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.3 million in Q3 2024 and troughed at -$3.0 million in Q4 2024.
- A 5-year average of $12823.5 and a median of $215000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income slumped 29785.71% in 2022, then surged 1124.24% in 2024.
- Over 5 years, Interest & Investment Income stood at $1.1 million in 2022, then gained by 16.0% to $1.3 million in 2023, then plunged by 330.49% to -$3.0 million in 2024, then soared by 107.11% to $215000.0 in 2025, then tumbled by 1384.19% to -$2.8 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$2.8 million, $215000.0, and $531000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | IDEAYA Biosciences | 3.66 Bn | 2.83 Bn | - | -1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.18 Mn |
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | 215,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | -64,000.00 |
| Mar 31, 2025 | 773,000.00 |
| Dec 31, 2024 | -3.02 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | -493,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 429,000.00 |
| Jun 30, 2023 | 226,000.00 |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -373,000.00 |
| Jun 30, 2022 | -825,000.00 |
| Mar 31, 2022 | -2.09 Mn |
| Dec 31, 2021 | -662,000.00 |
| Sep 30, 2021 | -46,000.00 |